butyl[(5-methylfuran-2-yl)methyl]amine, 95.0%, 10g

(R)-3-((tert-Butoxycarbonyl)amino)-4-methylpentanoic acid, 95.0%, 1g

2-Amino-6-hydroxypyridine, 98.0%, 1g

tert-Butyl (5-(hydroxymethyl)pyridin-2-yl)carbamate, 95.0%, 5g

Ethyl 2-amino-4-chlorobenzoate, 98%, 5g

4-Bromo-5-(tert-butyl)isoxazol-3-amine, 95.0%, 100mg

(3-Bromothiophen-2-yl)methanamine hydrochloride, 95+%, 5g

4-Methoxyphenylmethylsulfone, 98.0%, 1g

2-Methyl-2-pentene>95.0%(GC)5mL

4-(1-Ethyl-1 H -pyrazol-4-yl)-thiazol-2-ylamine, 100mg

GC capillary column ROTI®Cap-5, 15 m, 0.32 mm, 0.25 µm, 1 Piece(s)

7-BROMO-4-HYDROXYNAPHTHALENE-2-CARBOXYLIC ACID ETHYL ESTER, 95%, 5g

(E)-N-(4-(N-(3,4-dimethylisoxazol-5-yl)sulfamoyl)phenyl)-3-(p-tolyl)acrylamide, 98%, 10mg